Eton’s conjunctivitis treatment fails to win FDA nod; shares tumble
(Reuters) – Eton Pharmaceuticals Inc said on Friday that the U.S. Food and Drug Administration declined to approve its treatment for conjunctivitis, sending its shares tumbling nearly 20 percent in…